Programme for Government 2020-2021

  Our Policy and Campaigns Officer, Rona Johnson looks at the recently published Programme for Government 2020-2021 and some key aspects that Epilepsy Scotland...

New paediatric Epilepsy and Complex Needs Lead in Dumfries and Galloway

  NHS Dumfries and Galloway have appointed Sarah Gemmell as the new Epilepsy and Complex Needs Lead, based within the Children’s Community Team.

Cannabidiol approved as treatment option for Dravet and Lennox-Gastaut Syndrome

  Today (7/9/20) the Scottish Medicines Council (SMC) approved cannabidiol as a treatment option for those aged two years and over with Dravet or...

COVID19: returning to work safely

  Our Policy and Campaigns Officer, Rona Johnson provides information published by The Scottish Government for workers and employers returning to work during the...

Sodium Valproate – Government urged to apologise

  Today (08/07/20) the Independent Medicines and Medical Devices Safety Review (IMMDSR) was published, titled ‘First Do No Harm’.

New diagnostic video tool for people with epilepsy and their clinicians

  Our Policy & Campaigns Officer, Rona Johnson looks at a new patient and carer recorded video service for the diagnosis and management of...

Epilepsy and COVID19 report

  Our Policy & Campaigns Officer, Rona Johnson provides results to our survey looking at how COVID19 has impacted people with epilepsy.

Benefit changes during COVID19

  The Scottish Government has eased eligibility for some benefits to help people through Covid19.

Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) order – Chief Medical Officer response

  Following reports in England, Epilepsy Scotland had significant concerns about people with a learning disability and other additional needs being blanket contacted for...

Disability benefits roll out delayed due to Covid-19

  Our Policy & Campaigns Officer, Rona Johnson looks at how the roll out of new benefits being devolved to Scotland have been delayed...

Product categories